Mustang Bio (MBIO) Change in Cash (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Change in Cash of -$1.0 million for Q1 2026, down 113.64% year-over-year from $7.4 million in Q1 2025, and up 41.33% quarter-over-quarter from -$1.7 million in Q4 2025.
Mustang Bio (MBIO) Change in Cash (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Change in Cash for 11 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 113.64% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 83.81% YoY), while the FY2025 annual figure was $10.4 million, up 7291.03% from the prior year.
- Change in Cash advanced to -$1.0 million in Q1 2026 per MBIO's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $12.6 million in Q1 2022 and bottomed at -$42.7 million in Q2 2023.
- Historically, Change in Cash has averaged -$5.6 million across 5 years, with a median of -$1.7 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Cash sank 2789.67% — and 2025, when it surged 951.55%.
- Mustang Bio's Change in Cash stood at -$15.7 million in 2022, then soared by 78.81% to -$3.3 million in 2023, then jumped by 188.31% to $2.9 million in 2024, then slumped by 158.46% to -$1.7 million in 2025, then soared by 41.33% to -$1.0 million in 2026.
- Business Quant data shows MBIO's Change in Cash at -$1.0 million in Q1 2026, -$1.7 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | -1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.11 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Sep 30, 2025 | 6.33 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Mar 31, 2025 | 7.39 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | -743,000.00 |
| Jun 30, 2024 | 2.93 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | -3.33 Mn |
| Sep 30, 2023 | -5.82 Mn |
| Jun 30, 2023 | -42.71 Mn |
| Mar 31, 2023 | -17.81 Mn |
| Dec 31, 2022 | -15.71 Mn |
| Sep 30, 2022 | -16.01 Mn |
| Jun 30, 2022 | -14.85 Mn |
| Mar 31, 2022 | 12.60 Mn |
| Dec 31, 2021 | -11.26 Mn |
| Sep 30, 2021 | -9.04 Mn |